Rethinking Clinical Trials

FEBRUARY 13, 2023

One of the main challenges of cardiac surgery, in addition to the technical complexities, is the occurrence of low cardiac output syndrome. All infants and children less than 2 years of age undergoing open heart surgery on cardiopulmonary bypass were eligible for the study with exclusions for diseases that implied high severity pre-bypass.

Trials 130

Trials Clinical Trials Clinical Trials Research 130

Rethinking Clinical Trials

OCTOBER 13, 2022

The trial included adults 18 and older, ASA physical status III or IV, who had a major inpatient surgery with an anticipated duration of 2 hours or longer. Short-term outcomes, surgery length of time, and level of training of the anesthesiologist were also not different between the two groups. pctGR, @Collaboratory1.

Trials 130

Trials Clinical Trials Clinical Trials Nurses 130

Rethinking Clinical Trials

MAY 25, 2023

Tags #pctGR, @Collaboratory1 The post Grand Rounds May 19, 2023: Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis After a Fracture (Robert O’Toole, MD) appeared first on Rethinking Clinical Trials. Prophylaxis (chemical or mechanical) reduces risk deep vein thrombosis (DVT) by around 50%. -The

Trials 130

Trials Clinical Trials Clinical Trials Compliance 130

pharmaphorum

NOVEMBER 16, 2021

However third-line therapy is generally not very effective, and patients may have to resort to invasive therapy options like resective surgery and vagal nerve stimulation. “We look forward to the full technology appraisal guidance (TAG) which is due to be published in early December 2021,” he added.

Drugs 98

Drugs Medicine Clinical Trials Clinical Trials 98

pharmaphorum

OCTOBER 29, 2021

Merck is the obvious partner for that ambition as Keytruda is in the ascendency among checkpoint inhibitors for TNBC, having also recently also picked up an FDA approval pre-surgery alongside chemotherapy in the neoadjuvant setting, as well as in the post-surgery (adjuvant) setting as a monotherapy, to prevent tumours from recurring.

Trials 52

Trials Sales FDA Approval Production 52

World of DTC Marketing

DECEMBER 13, 2021

As cancer survival rates rise, so do the price tags of life-saving treatments. OPENING: American cancer patients spent more than $21 billion on their care in 2019. billion included out-of-pocket costs of $16.22 billion and patient time costs of $4.87

Drugs 55

Drugs FDA Approval Medicine Containment 55

Rethinking Clinical Trials

AUGUST 28, 2023

Tags #pctGR, @Collaboratory1 The post Grand Rounds July 21, 2023: Implementing New Care Pathways for Low Back Pain in Academic Healthcare Systems: Early Lessons from IMPACt-LBP (Christine Goertz, DC, PhD; Adam Goode, DPT, PhD) appeared first on Rethinking Clinical Trials.

Trials 130

Trials Research Medicine Doctors 130